2017 Group Company Advanced Collective and Advanced Individual
Release time:
2020-08-14
2017 Group Company Advanced Collective, Advanced Individual
1. Advanced Collective
Advanced Enterprise ():
Daye Peak Cement Co., Ltd.
Pharmaceutical Company Jinxi Pharmaceutical Factory
Advanced Party Organization (2 ):
CPC Yunnan Jianfeng Cement Co., Ltd. Party Branch
CPC Jinhua Pharmaceutical Co., Ltd. Party Branch
Advanced Civilization Workshop (Department)( ):
Peak Communication Cable Co., Ltd. Cable Workshop
Pharmaceutical Company Quality Department Central Laboratory
Pharmaceutical Company Jinxi Pharmaceutical Factory Raw Material Workshop
Yunnan Peak Cement Co., Ltd. Marketing Department
Daye Peak Cement Co., Ltd. Quality Control Department
Advanced Civilization Team (8 ):
Jianfeng Health Technology Company Traditional Chinese Medicine Toxic Decoction Pieces Group
Jianfeng Group Office Security Group
Daye Jianfeng Cement Co., Ltd. Waste Heat Power Generation Minister day shift
Jianfeng Pharmacy Shijinge Pharmacy
Jianfeng International Trade Co., Ltd. Xiaohuang Village Warehouse
Jinhua Medicine Co., Ltd. Primary Hospital Department
daye peak cement co., ltd. manufacturing department inspection class B
Yunnan peak cement co., ltd. manufacturing department packaging group 1 class
advanced trade union organization (1 ):
Yunnan Jianfeng Cement Co., Ltd. Trade Union Committee
2. Advanced Individual
Outstanding Employees (10 ):
Peak Health Technology Company Ye Xuying
Peak International Trade Co., Ltd. Ruan Weihang
Peak Group Office Chi Lifan
Peak Communication Cable Co., Ltd. Fuweiyan
Pharmaceutical Company Finance Department Qian Xiaojing
Pharmaceutical Company Jinxi Pharmaceutical Factory Fang Hongying
Daye Peak Cement Co., Ltd. Yang Zhendong
Daye Peak Cement Co., Ltd. Hu Ximing
Yunnan Peak Cement Co., Ltd. Su Dabin
Yunnan Peak Cement Co., Ltd. Feng Shao yi
Innovation Expert (5 ):
Pharmaceutical Company Jinxi Pharmaceutical Factory Building Jianfeng
Tianjin Jianfeng Natural Products Company Sun Huageng
Daye Jianfeng Cement Co., Ltd. Luo Dengxiang
Jianfeng Communication Cable Co., Ltd. Guo Zhijian
Yunnan Jianfeng Cement Co., Ltd. Yao Wenwei
Outstanding Management Workers (3 ):
Daye Jianfeng Cement Co., Ltd. Liu Feng
Yunnan Jianfeng Cement Co., Ltd. Tan Guojian
Tianjin Jianfeng Natural Products Co., Ltd. Liu Dan
Excellent Salesman (5 ):
Daye Peak Cement Co., Ltd. Wang Zhengjia
Peak Pharmacy Xinhua Pharmacy Wang Xiuling
Yunnan Peak Cement Co., Ltd. Hu Xiaodong
Peak International Trade Co., Ltd. Du Lin
Jinhua Pharmaceutical Company Zheng Yongjun
3. Advanced Individual
Safety and Environmental Protection Advanced Worker (4 ):
Peak Communication Cable Co., Ltd. Li Jianxin
Daye Peak Cement Co., Ltd. Wang Xuejun
Yunnan Peak Cement Co., Ltd. Fang Xuexing
Pharmaceutical Company Qiubin Pharmaceutical Factory Sheng Junyong
Advanced Party Worker (1 name):
Yunnan Jianfeng Cement Co., Ltd. Fang Xuhua
Outstanding Communist Party Member (
Jinhua Pharmaceutical Company Wu Weisheng
Daye Peak Cement Co., Ltd.
Peak Communication Cable Co., Ltd. Zhang Ci
Yunnan Peak Cement Co., Ltd.
advanced trade union workers (2
Daye Jianfeng Cement Co., Ltd.
Yunnan Jianfeng Cement Co., Ltd.
Trade Union Activists (2
Pharmaceutical Company Qiubin Pharmaceutical Factory
Daye Jianfeng Cement Co., Ltd.
Rookie Employee (3
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page